Medtronic (MDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medtronic (MDT)

MDT 92.21

+2.4%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Thomas J Pittman who wrote ()	5/23/2000 9:32:00 AM
From: Jack Hartmann	of 687

09:05 ET Medtronic (MDT) 50 5/16: SG Cowen making cautious comments ahead of Wed's earnings; expects EPS to be inline with Street's $0.26 but not to beat by a penny as some had expected; looks for revs to be in line but pacemaker sales to be sluggish ($365-370MM), up just 2-4%; rates stock NEUTRAL. Separately, Goldman Sachs is removing MDT from its U.S. Select List due to price appreciation and adding Guidant (GDT); believes GDT's current share price (trading at approx. 25X our 2001 EPS est. of $1.93) does not reflect the company's strong franchise. From briefing.com ********* Hmmm. Some selloff after earnings seems to be brewing. Jack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next